Jubilee Metals reports solid Q1 performance and progress toward South African asset sale 17 October 2025
Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video) 14 October 2025
CMC Markets Plc (CMCX.L) Stock Analysis: Assessing the 22% Upside Potential for Investors 22 October 2025
Cranswick PLC (CWK.L): Investor Outlook Highlights 14% Potential Upside Amid Consistent Growth 22 October 2025
Carnival PLC (CCL.L) Stock Analysis: A Look at Strong Buy Ratings Amidst Market Volatility 22 October 2025
Breedon Group PLC (BREE.L) Stock Analysis: A 49.72% Upside Potential with Robust Buy Ratings 22 October 2025
Jubilee Metals reports solid Q1 performance and progress toward South African asset sale 17 October 2025
Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video) 14 October 2025
CMC Markets Plc (CMCX.L) Stock Analysis: Assessing the 22% Upside Potential for Investors 22 October 2025
Cranswick PLC (CWK.L): Investor Outlook Highlights 14% Potential Upside Amid Consistent Growth 22 October 2025
Carnival PLC (CCL.L) Stock Analysis: A Look at Strong Buy Ratings Amidst Market Volatility 22 October 2025
Breedon Group PLC (BREE.L) Stock Analysis: A 49.72% Upside Potential with Robust Buy Ratings 22 October 2025
Nerdy Inc. (NRDY) Stock Analysis: Exploring a Strategic Opportunity with 28% Upside Potential 10 July 2025
Viant Technology Inc. (DSP) Stock Analysis: Insights into a Potential 53% Upside for Tech Investors 10 July 2025
Cytek Biosciences (CTKB) Stock Analysis: 60% Potential Upside Amid Healthcare Innovations 10 July 2025
Grab Holdings Limited (GRAB) Stock Analysis: Strong Buy Ratings and 16% Potential Upside 10 July 2025
Pacific Biosciences of California (PACB) Stock Analysis: Is the 38.85% Potential Upside Worth the Risk? 10 July 2025
Alpha Tau Medical Ltd. (DRTS): Investor Outlook Reveals 168% Potential Upside with Promising Oncology Innovations 10 July 2025
Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Biotech Innovator Positioned for Growth Amidst Clinical Advances 10 July 2025
Aurora Cannabis Inc. (ACB): Investor Outlook Highlights Revenue Growth and Analyst Ratings 10 July 2025
Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech Gem with 355% Upside Potential 10 July 2025
Varex Imaging Corporation (VREX) Stock Analysis: A Healthcare Imaging Leader With Nearly 97% Potential Upside 10 July 2025
TotalEnergies SE (TTE) Stock Analysis: A Strong Dividend Play with a 10.96% Upside Potential 10 July 2025
Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 95% Potential Upside in the Medical Device Sector 10 July 2025
Gossamer Bio, Inc. (GOSS) Stock Report: Analysts See a Potential Upside of 459%—Is It Worth the Risk? 10 July 2025
Candel Therapeutics, Inc. (CADL) Stock Analysis: A Promising 261% Upside Potential with Robust Analyst Support 10 July 2025
XOMA Royalty Corporation (XOMA) Stock Analysis: A Biotech Gem with 133% Potential Upside 10 July 2025
NANO-X IMAGING LTD (NNOX): Investor Outlook Reveals 67.95% Potential Upside in the Innovative Medical Imaging Sector 10 July 2025
National Research Corporation (NRC) Stock Analysis: A High ROE Healthcare Play with a 2.86% Dividend Yield 10 July 2025
One Health Group Record Patient Growth and a Strategic Leap with New Surgical Hubs (Video) 27 June 2025
AstraZeneca’s Tezspire recommended for EU approval in chronic rhinosinusitis with nasal polyps 22 September 2025
Ruffer Investment Company Annual Report 2025: Shock resistance and satisfactory returns 3 October 2025
Goodbody Health investor presentation – Diagnostic services, health and wellness products 12 January 2022
Jubilee Metals reports solid Q1 performance and progress toward South African asset sale 17 October 2025
Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video) 14 October 2025
CMC Markets Plc (CMCX.L) Stock Analysis: Assessing the 22% Upside Potential for Investors 22 October 2025
Cranswick PLC (CWK.L): Investor Outlook Highlights 14% Potential Upside Amid Consistent Growth 22 October 2025
Carnival PLC (CCL.L) Stock Analysis: A Look at Strong Buy Ratings Amidst Market Volatility 22 October 2025
Breedon Group PLC (BREE.L) Stock Analysis: A 49.72% Upside Potential with Robust Buy Ratings 22 October 2025
